INS and type 2 diabetes mellitus: Reduction of Reg1 was linked with the pathogenesis of impaired glucose tolerance of diabetes [14], while treatment with Reg1 protein improved the islet β-cells ability to secrete insulin in rat models of diabetes, indicating its role in the pathogenesis of type 2 diabetes.